THE EFFECT OF TIME TO CASTRATION RESISTANCE ON SURVIVAL IN PATIENTS WITH METASTATIC HORMONE-NAIVE PROSTATE CANCER: A MULTICENTER RETROSPECTIVE STUDY

被引：0
|
作者：
Tokui, Noriko
Hatakeyama, Shingo
Narita, Satoshi
Yoneyama, Takahiro
Hashimoto, Yasuhiro
Ohyama, Chikara
机构：
来源：
JOURNAL OF UROLOGY | 2020年 / 203卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP37-12
引用
收藏
页码：E564 / E565
页数：2
相关论文
共 50 条
  • [31] Enzalutamide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: A retrospective Korean multicenter study in a real-world setting
    Jung, Seung Il
    Kim, Myung Soo
    Jeong, Chang Wook
    Kwak, Cheol
    Hong, Sung Kyu
    Kang, Seok Ho
    Joung, Jae Young
    Lee, Seung Hwan
    Yun, Seok Joong
    Kim, Tae-Hwan
    Park, Sung Woo
    Jeon, Seong Soo
    Kang, Minyong
    Lee, Ji Youl
    Chung, Byung Ha
    Hong, Jun Hyuk
    Ahn, Hanjong
    Kim, Choung-Soo
    Kwon, Dong Deuk
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (01) : 19 - 27
  • [32] Docetaxel Rechallenge Improves Survival in Patients With Metastatic Castration-resistant Prostate Cancer: A Retrospective Study
    Hung, Sheng-Chun
    Chang, Li-Wen
    Li, Jian-Ri
    Wang, Shian-Shiang
    Yang, Cheng-Kuang
    Chen, Chuan-Shu
    Lu, Kevin
    Chen, Cheng-Che
    Wang, Shu-Chi
    Lin, Chia-Yen
    Chen-Li Cheng
    Ou, Yen-Chuan
    Chiu, Kun-Yuan
    IN VIVO, 2021, 35 (06): : 3509 - 3519
  • [33] The Effect of Time to Castration Resistance on Overall Survival and Success of Docetaxel Treatment in Castration Resistant Prostate Cancer Patients
    Suer, Evren
    Hamidi, Nurullah
    Akpinar, Cagri
    Gokce, Mehmet Ilker
    Gulpinar, Omer
    Turkolmez, Kadir
    Beduk, Yasar
    Baltaci, Sumer
    UROLOGY JOURNAL, 2019, 16 (05) : 453 - 457
  • [34] Genomic profiling of hormone-naive lymph node metastases in patients with prostate cancer
    Paris, Pamela L.
    Hofer, Matthias D.
    Albo, Giancarlo
    Kuefer, Rainer
    Gschwend, Juergen E.
    Hautmann, Richard E.
    Fridyland, Jane
    Simko, Jeffrey
    Carroll, Peter R.
    Rubin, Mark A.
    Collins, Colin
    NEOPLASIA, 2006, 8 (12): : 1083 - U54
  • [35] Association of tumor burden with the eligibility of upfront therapy in patients with castration-naive prostate cancer: A multicenter retrospective study
    Iwamura, Hiromichi
    Hatakeyama, Shingo
    Narita, Shintaro
    Sakurai, Toshihiko
    Kawamura, Sadafumi
    Hoshi, Senji
    Saito, Fumitada
    Kawaguchi, Toshiaki
    Mitsuzuka, Koji
    Ito, Akihiro
    Tsuchiya, Norihiko
    Arai, Yoichi
    Habuchi, Tomonori
    Ohyama, Chikara
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [36] Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
    Miyake, Hideaki
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (03) : 1391 - 1396
  • [37] A retrospective feasibility study of biweekly docetaxel in patients with high-risk metastatic castration-naive prostate cancer
    Yoon, Sang Eun
    Kim, Youjin
    Cho, Jangho
    Kang, Minyong
    Sung, Hyun Hwan
    Jeon, Hwang Gyun
    Jeong, Byoung Chang
    Seo, Seong Il
    Jeon, Seong Soo
    Lee, Hyun Moo
    Choi, Han Yong
    Lee, Su Jin
    Park, Se Hoon
    BMC UROLOGY, 2019, 19
  • [38] Interventional Study in metastatic, hormone naive Prostate Cancer
    Rexer, H.
    UROLOGE, 2015, 54 (11): : 1613 - 1616
  • [39] CYTOREDUCTIVE RADICAL PROSTATECTOMY (CRP) IS FEASIBLE IN MEN WITH HORMONE-NAIVE, METASTATIC PROSTATE CANCER (MPCA).
    Heidenreich, Axel
    Karnes, Jeff. R.
    Briganti, Alberto
    Shariat, Shahrokh
    Porres, Daniel
    Fossati, Nicola
    Montorsi, Francesco
    Suardi, Nazareno
    Pfister, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E721 - E721
  • [40] Chemotherapy in metastatic hormone-naive prostate cancer: Pooled analysis of randomized clinical trials.
    Fabbri, Paolo
    Stocchi, Lucia
    Nicoletti, Stefania
    Drudi, Fabrizio
    Tamburini, Emiliano
    Nicolini, Mario
    Gianni, Lorenzo
    Pasini, Giuseppe
    Montanari, Francesco
    Tassinari, Davide
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
12345